ArticleBreast cancer research and treatment2019

Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.

Erik Hedrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.